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NIH project: 5 ROl EY07006-04 
This progress report covers the period from June 1, 1990 to 
March 31, 1992. 
Measurements have been made from the lenses of 85 patients 
with Type I Diabetes Mellitus (DM) at an excitation wavelength of 
406.7 nm and 117 patients at an excitation wavelength of 441.6 nm. 
Measurements at the 406.7 nm excitation have also been made from 43 
patients with Type II DM and 18 age matched non-diabetic subjects. 
These later measurements from Type II patients were performed 
through an undilated pupil. 
Measurements have also been performed using excitation 
wavelengths of 488 and 514 nm from an air cooled Argon laser which 
was incorporated into the measurement system. A total of 26 
diabetic subjects and 10 non-diabetic subjects have been measured 
at these excitation wavelengths. Figure 1 a-d illustrate lens 
fluorescence spectra obtained from the nucleus of a 33 year old 
Type I diabetic patient (duration 8 years) at the 4 different 
excitation wavelengths used. 
We have also conducted a pilot study in collaboration with Dr. 
L.T. Chylack and Dr. J. Liang using 31 enucleated eyes obtained 
from the National Disease Research Interchange (NDRI). The aim of 
this study was to investigate possible correlations between 
clinical lens gradings, lens fluorescence measurements and lens 
protein fractions using the same lenses. 
Analysis of the results using the patient data accumulated at 
the 406.7 and 441.6 nm excitation wavelengths was performed using 
the fluorescence/Rayleigh line (F/R) ratios obtained from the lens 
nucleus. Figure 2 a, b illustrate the data obtained at 406.7 nm. In 
this case it is evident that, at a fixed excitation wavelength, 
normalized lens fluorescences calculated as the F/R ratio provided 
a more sensitive discrimination between diabetic and non-diabetic 
lenses (Fig 2a) than the more traditional total lens fluorescence 
measurements (Fig 2b). Thus this method of analysis facilitates a 
quantitative investigation of more specific lens fluorophor species 
by restricting excitation to a single wavelength and restricting 
the resulting measured intrinsic fluorescence to a 10 nm wavelength 
band about the wavelength at which the peak spectral fluorescence 
intensity occurs. 
A significant relationship between F/R ratio and age was 
demonstrated at the 406.7 nm excitation wavelength for non-diabetic 
subjects (Fig 3). The data at this wavelength, for both diabetic 
and non-diabetic subjects, indicated that the F/R ratio increased 
with age up to approximately age 50, while lenses older than age 50 
showed little change with age. In contrast, the results at 441.6 nm 
excitation (Fig 4) showed little change with age in lenses younger 
than age 30 and increasing F/R ratios with increasing age in the 
older subjects. This would suggest that there may be a conversion 
of the shorter excitation wavelength (406.7 nm) lens fluorophor 
species to species with excitation wavelengths showing greater 
efficiencies at longer excitation wavelengths (441.6 nm) as the 
lens ages. 
The results at the 406.7 nm excitation wavelength were also 
correlated with Hemoglobin Ale levels or average glycemic control. 
Figure 5 illustrates the relationship between increasing Ale levels 
and age corrected increasing F/R ratios. The age correction was 
implemented using the age relationship in Fig 3. The solid line is 
the result of the regression analysis demonstrating a significant 
relationship with a correlation coefficient of 0.9. Thus at the 
406.7 nm excitation wavelength there appears to be a significant 
association between the average level of glycemic control and 
increased lens fluorescence. 
The study on Type II diabetic patients was performed using 
only the 406.7 nm excitation wavelength. The measurements were 
performed through the undilated pupil and measurements were 
restricted to just the one excitation wavelength in order to 
facilitate a faster measurement time and better patient compliance. 
The aim of the study was to investigate whether the same degree of 
F/R ratio discrimination was attained in a population of Type II DM 
patients as was observed in the Type I patients. The results from 
these measurements did not demonstrate the same degree of 
discrimination as that seen in Type I patients. Thus while on 
average the diabetic patients had higher F/R ratios, the difference 
between the diabetic patients and the age matched controls was not 
remarkable. It was felt that this observation may be due to the 
fact that the ages of the Type II patients were all over 50 years 
and in an age range where there may have been conversion of this 
fluorophor to longer wavelength species and where we had previously 
observed little change in F/R ratios with age, at this excitation 
wavelength. Measurements were then extended to include excitation 
wavelengths of 441.6 and 488 nm. Preliminary results at these 
excitation wavelengths demonstrate, on average a factor of 2 
greater F/R ratios in the diabetic lenses than the non-diabetic 
lenses. if these results are consistent, then it is anticipated 
that these measurements could be used to non-invasively screen 
populations for detecting possible undiagnosed Type II diabetes. 
These results have provided the basis for a SBIR application 
through Laser Atlanta. 
The pilot study aimed at investigating possible correlations 
between F/R ratios, clinical lens color evaluations and extracted 
protein fluorescences were performed using enucleated eyes obtained 
from NDRI. The age range of these 31 eyes was between 65 and 101 
years. 
Color photographs of these lenses were taken after removal of 
the corneas. These photographs were analyzed for color purity using 
the LOCS-II grading protocols. lens fluorescences were then 
measured at excitation wavelengths of 406.7 nm and 441.6 nm. The 
use of longer excitation wavelengths was not possible at the time 
of this study as the Argon laser had not been ordered. Following 
lens fluorescence measurements, the lenses were removed from the 
globe, frozen at -20°C and lens proteins were subsequently 
extracted for analysis. The excised lenses were decapsulized, 
homogenized and the resulting protein separated into its water 
soluble and insoluble components. Non-tryptophan fluorescence was 
measured from these fractions. The results from these measurements 
indicated that at the 406.7 nm excitation there was no significant 
association with any of the other measured parameters. At the 441.6 
nm excitation, however, there was a significant association between 
F/R ratios and lens purity evaluated at the lens nucleus (p=.044) 
and with both the water soluble and water insoluble lens protein 
fractions (p=.04). The lack of association between F/R ratios at 
406.7 nm excitation and lens color or non-tryptophan fluorescence 
is probably a reflection of the lack of change with age of this 
particular fluorophor in the older lenses studied here. 
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Propcaed Wodel for F/R(ACE) 
F /R(ACE)= .38(A.GE) -.0023(AGE)-2 
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